SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Concord Biotech informs about newspaper publication

06 Jul 2026 Evaluate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Concord Biotech has enclosed copies of the newspaper advertisements published for the information of the shareholders, in compliance with the applicable provisions of the SEBI Listing Regulations and the Companies Act, 2013, read with the rules made thereunder. The advertisements contain information regarding the Company's 41st Annual General Meeting, notice of candidature for the office of Director, the record date, and the availability of the e-voting facility. Financial Express (English, All Editions); and Financial Express (Gujarati, Ahmedabad Editions).

The above information is a part of company’s filings submitted to BSE.

Concord Biotech Share Price

1284.00 3.95 (0.31%)
06-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1913.05
Dr. Reddys Labs. 1368.75
Cipla 1471.25
Zydus Lifesciences 1148.05
Lupin 2492.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: